
Keywords: Ethyl All-Cis-5,8,11,14,17-Eicosapentaenoate; Metabolic Syndrome; Triglycerides; ALT; alanine aminotransferase; BMI; body mass index; EPA; eicosapentanoic acid; EPA-E; eicosapentanoic acid ethyl ester; NAFLD; nonalcoholic fatty liver disease; NAS; NAFLD a